Literature DB >> 20586617

TMPRSS2:ERG fusion gene and androgen-ablation therapy in prostate cancer.

Elisabetta Baldi, Lorella Bonaccorsi, Gabriella Nesi, Sergio Serni, Gianni Forti, Lucio Luzzatto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20586617     DOI： 10.5858/2009-0499-LE.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  2 in total

Review 1.  Androgen regulation of prostate cancer: where are we now?

Authors:  G Corona; E Baldi; M Maggi
Journal:  J Endocrinol Invest       Date:  2011-02-04       Impact factor: 4.256

2.  TMPRSS2-ERG Fusion Gene Expression in Prostate Tumor Cells and Its Clinical and Biological Significance in Prostate Cancer Progression.

Authors:  Jason St John; Katelyn Powell; M Katie Conley-Lacomb; Sreenivasa R Chinni
Journal:  J Cancer Sci Ther       Date:  2012-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.